1-octadecyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Term ID

CHEBI:86252

Synonyms

(2R)-2-{[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-(octadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
PC(O-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Definition

A phosphatidylcholine O-40:6 in which the alkyl and the acyl groups at positions 1 and 2 are octadecyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.

References

HMDB:HMDB0013422
LIPID_MAPS_instance:LMGP01020110

Ontology

ChEBI ( EBI )

Relationships

is a type of: 2-acyl-1-alkyl-sn-glycero-3-phosphocholine phosphatidylcholine O-40:6

2-acyl-1-alkyl-sn-glycero-3-phosphocholine phosphatidylcholine O-40:6 Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Show first 5 Terms

Phenotype

Phenotype resulting from 1-octadecyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Phenotype where environments contain 1-octadecyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Phenotype modified by environments containing 1-octadecyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Human Disease Model